Richard Gu is a Vice President at March Capital, where he focuses on AI investments across healthcare, life sciences, and enterprise technology. He works closely with March portfolio companies across the healthcare and life sciences ecosystem, including Generate: Biomedicines, Tessera Therapeutics, Lila Sciences, Suki, and Overjet. His areas of focus span biotech, healthcare software, clinical workflows, and care delivery, with a particular interest in how technology and AI can improve healthcare outcomes and efficiency. 

,